Literature DB >> 15795559

Nuclear peroxisome proliferator-activated receptors and thiazolidinediones.

Achikam Grinberg1, Kyung W Park.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15795559     DOI: 10.1097/01.aia.0000157485.91241.0b

Source DB:  PubMed          Journal:  Int Anesthesiol Clin        ISSN: 0020-5907


× No keyword cloud information.
  2 in total

1.  Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages.

Authors:  Bardia Askari; Jenny E Kanter; Ashley M Sherrid; Deidre L Golej; Andrew T Bender; Joey Liu; Willa A Hsueh; Joseph A Beavo; Rosalind A Coleman; Karin E Bornfeldt
Journal:  Diabetes       Date:  2007-01-26       Impact factor: 9.461

2.  Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.

Authors:  Hai-Ling Liu; Yang-Gen Lin; Jing Wu; Hong Sun; Zhi-Cheng Gong; Ping-Cheng Hu; Ji-Ye Yin; Wei Zhang; Dan Wang; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Eur J Clin Pharmacol       Date:  2008-04-26       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.